Moringa oleifera (Horseradish Tree)

CONSULTATION WITH A SPECIALIST

Product code:
$6.6
We recommend installing the IMO messenger for quick contact.
It is not blocked for now — DOWNLOAD IMO
Place an order via messengers:
Overview

Moringa oleifera (Horseradish Tree)

Product Name: Моринга масляничная, Moringa oleifera, Meerrettichbaum, Moringa, Moringa, المورينغا, มะรุม

Synonyms: Моринга, Дерево хрена, Барабанное дерево, Беновое дерево, Бен-ойл, Моринга олифейра, Моринга лекарственная, Moringa, Horseradish tree, Drumstick tree, Ben tree, Moringa-baum, Meerrettichbaum, Moringa medicinal, Moringa árbol, Moringa oléifère, Arbre ben, شجرة المورينغا, شجرة الفجل, มะรุม, ไม้มะรุม, พืชมหัศจรรย์

Main Indications for Use of Moringa oleifera: Fatty hepatosis, hyperglycemia, dyslipidemia, arterial hypertension, osteoarthritis, osteoporosis, iron-deficiency anemia, bacterial infection of the upper respiratory tract, chronic bronchitis, autoimmune dermatoses, gastric ulcer, diabetic nephropathy, irritable bowel syndrome, chronic colitis, hypothyroidism, obesity, chronic fatigue syndrome, hyperestrogenism, premenstrual syndrome, erectile dysfunction, immunodeficiency states, colds of viral etiology.

Use of Moringa oleifera in Mixtures and Complexes: Allergic rhinitis, viral hepatitis B, metabolic syndrome, chronic obstructive pulmonary disease, atherosclerosis, xerophthalmia, acne, prostatic hyperplasia, chronic fatigue after infectious diseases, type II diabetes mellitus with concomitant obesity, arterial hypotension, neurocirculatory dystonia, sleep disorders, anemia of chronic diseases, post-COVID syndrome, coronary heart disease.

Pharmacological Properties of Moringa oleifera: antioxidant, hypolipidemic, hypoglycemic, hepatoprotective, antibacterial, anti-inflammatory, antiseptic, antitumor, adaptogenic, general tonic, immunomodulatory, analgesic, antipyretic, spasmolytic, antimycotic, anthelmintic, rejuvenating, neuroprotective, cardioprotective, wound-healing, diuretic, tonic, lactogenic, soothing.


Dosage of Pharmaceutical Forms — Moringa oleifera

Powder — Moringa oleifera

Indications (Powder): Fatty hepatosis, hyperglycemia, dyslipidemia, arterial hypertension, osteoarthritis, osteoporosis, iron-deficiency anemia, chronic fatigue syndrome, hypothyroidism, autoimmune dermatoses, obesity, premenstrual syndrome, anemia of chronic diseases.

Standard Dosage (Powder): Adults are recommended to take 3–5 g of moringa leaf powder per day, divided into 2 doses — morning and evening, 30 minutes before meals, washed down with warm water.

Enhanced Dosage (Powder): Up to 7–10 g of powder per day (in 2–3 doses) is recommended for type II diabetes mellitus, osteoporosis, pronounced hypothyroidism, dyslipidemia, and severe iron-deficiency state. Use no more than 21 consecutive days, then a 7-day break.

Maximum Dosage (Powder): Should not exceed 12 g per day. Such a dosage is permissible only under specialist supervision for autoimmune skin diseases, pronounced hyperlipidemia, or acute inflammatory manifestations accompanied by metabolic intoxication.

Preventive Dosage (Powder): 1–2 g of powder per day in the morning. Recommended for patients with hypothyroidism, iron metabolism disorders, osteopenia, chronic fatigue syndrome, and vegetative-vascular dystonia. Take 20 days per month, course up to 3 consecutive months.

Pediatric Dosage (Powder): Use is permissible in children over 6 years of age with a body weight from 20 kg. Starting dose — 500 mg per day, can be increased to 1 g with good tolerance. Recommended for anemia, hypotrophy, and weakened immunity. The child's gender is not a factor.

Contraindications (Powder): Individual intolerance. Patients with hypotension, pronounced hypokalemia, acute inflammatory bowel diseases. Data on contraindications during pregnancy, lactation, and in childhood under 6 years of age have not been scientifically registered.

Side Effects (Powder): Possible: diarrhea, flatulence, decreased blood pressure, nausea. All effects are observed at doses above 10 g per day and with prolonged use without a break.

Adjustment for Patient Body Weight (Powder): For body weight below 60 kg — the dosage is reduced by 25%. For weight above 90 kg — a correction of +20% of the standard dosage is possible.

Preparation Method (Powder): To obtain 100 g of powder, only fresh ripe moringa leaves are used. The leaves are washed, dried in the shade at a temperature not exceeding 40 °C for 48 hours until complete loss of moisture. Then ground into powder on a stone or ceramic mortar or in a low-speed mill. The powder is sifted through a sieve with a mesh size of 0.5 mm. The finished powder is packaged in an airtight glass or ceramic container.

Storage Conditions and Shelf Life (Powder): Store in a tightly closed glass container, in a dry, dark place at a temperature of +10 °C to +25 °C, away from sources of electromagnetic radiation. Do not use metal packaging. Shelf life — up to 12 months. After opening, use within 60 days.


Dry Extract — Moringa oleifera

Indications (Dry Extract): Hyperglycemia, fatty hepatosis, chronic colitis, type II diabetes mellitus, anemia of chronic diseases, hyperestrogenism, osteoarthritis, premenstrual syndrome, autoimmune dermatoses, hypothyroidism, chronic fatigue.

Standard Dosage (Dry Extract): Standardized dry moringa leaf extract (10:1 content) is taken at 300–500 mg 1–2 times a day before meals. Washed down with warm water or dissolved in 100 ml of water at a temperature of 40–45 °C.

Enhanced Dosage (Dry Extract): Up to 1000 mg per day is recommended for pronounced hypothyroidism, chronic inflammation of the large intestine, chronic fatigue syndrome, and pronounced hyperglycemia. Intake up to 14 days, then a 7-day break.

Maximum Dosage (Dry Extract): No more than 1500 mg of dry extract per day. Maximum dosages are indicated for resistant hyperglycemia, severe metabolic disorders, autoimmune skin manifestations, and recovery after viral infections.

Preventive Dosage (Dry Extract): 150–250 mg once daily in the morning, course of 20 days per month with repetition for 3 months. Recommended for a tendency to dyslipidemia, subclinical hypothyroidism, osteopenia, seasonal fatigue, and vegetative-vascular instability.

Pediatric Dosage (Dry Extract): Dry extract is permissible in children over 8 years of age and body weight from 25 kg at a dose of 50–100 mg per day. Used for functional iron-deficiency anemia, hypovitaminosis, and prolonged respiratory diseases. The child's gender does not matter.

Contraindications (Dry Extract): Individual intolerance, pronounced arterial hypotension, acute hyperkinesis, convulsive states. Reliable data on contraindications during pregnancy, lactation, and in children under 8 years of age are absent.

Side Effects (Dry Extract): Registered: dyspepsia, decreased blood pressure, dizziness when doses exceed 1200 mg per day, especially in patients with body weight less than 50 kg.

Adjustment for Patient Body Weight (Dry Extract): For patients with body weight below 60 kg, a 30% dosage reduction is recommended. For body weight over 90 kg, a correction up to +20% of the standard dose is possible.

Preparation Method (Dry Extract): To obtain 100 g of dry extract, 1000 g of dried moringa leaves are required. The leaves are extracted for 8 hours at a temperature of 55 °C in 70% ethanol. Then filtered, concentrated in a water bath to reduce the volume 5 times, and dried at a temperature not exceeding 45 °C in a vacuum dryer to a powder-like form. The finished extract is packaged in an airtight opaque container.

Storage Conditions and Shelf Life (Dry Extract): Store in a tightly closed ceramic or glass container at a temperature of +10 °C to +20 °C, in a darkened place protected from moisture and electromagnetic radiation. Shelf life — up to 24 months. After opening, use within 60 days.


Alcohol-Based Tincture — Moringa oleifera

Indications (Tincture): Hyperglycemia, dyslipidemia, autoimmune dermatoses, osteoarthritis, premenstrual syndrome, irritable bowel syndrome, chronic colitis, iron-deficiency anemia, hypothyroidism, hyperestrogenism.

Standard Dosage (Tincture): 20–25 drops (about 1 ml) twice daily, diluted in 50 ml of room-temperature water, 15–20 minutes before meals. Course of intake — 21 days, then a 7-day break.

Enhanced Dosage (Tincture): Up to 1.5 ml (30 drops) twice daily is permissible for pronounced inflammatory skin conditions, exacerbation of colitis, severe hyperglycemia, and hormonal imbalance. Duration — no more than 10 consecutive days.

Maximum Dosage (Tincture): 2 ml (40 drops) twice daily — the maximum permissible dose, used only short-term (up to 5 days) for pronounced clinical manifestations of chronic autoimmune conditions or hormonal instability. Requires medical supervision.

Preventive Dosage (Tincture): 10–15 drops once daily in the morning, in courses of 20 days with a 10-day break. Recommended for subclinical hypothyroidism, periodic hyperglycemia, fatigue, symptoms of premenstrual tension, and weakened immune defense in the off-season.

Pediatric Dosage (Tincture): Contraindicated for children under 12 years of age. For adolescents from 12 years of age (body weight from 35 kg), intake of 5–10 drops once daily, diluted in water, is permissible under adult supervision. Used for anemia, menstrual cycle disorders, and avitaminosis.

Contraindications (Tincture): Pregnancy, lactation, alcoholism, organic liver diseases, convulsive states, individual intolerance to alcohol or plant components. In children under 12 years of age — strictly contraindicated.

Side Effects (Tincture): May be observed: dizziness, increased peristalsis, feeling of heat, decreased blood pressure, bitterness in the mouth. Most pronounced when the dosage exceeds 2 ml per day.

Adjustment for Patient Body Weight (Tincture): For patients with body weight less than 60 kg — a 25% dosage reduction. For patients with body weight more than 90 kg — a dosage increase up to +20% of the base is permissible.

Preparation Method (Tincture): To prepare 100 ml of tincture, 20 g of dry crushed moringa leaves and 80 ml of 40% food-grade ethyl alcohol are used. The leaves are placed in a dark glass container, poured with alcohol, and infused for 14 days at a temperature of 20–22 °C in a dark place, with daily shaking. Then the tincture is strained through dense gauze and stored in a dark container.

Storage Conditions and Shelf Life (Tincture): Store in a dark glass container, at a temperature of +8 °C to +25 °C, away from sources of heat, light, and electromagnetic radiation. Shelf life — up to 24 months. After opening, use within 90 days.


Oil Infusion — Moringa oleifera

Indications (Oil Infusion): Autoimmune dermatoses, chronic dermatitis, psoriasis, eczema, seborrheic dermatitis, osteoarthritis, local joint inflammations, trophic skin changes, dryness of mucous membranes, dyshormonal mastopathy.

Standard Dosage (Oil Infusion): Externally — apply 3–5 ml to affected skin areas twice daily. For applications to joints — up to 10 ml, rub in with light movements for 5 minutes. Internal intake — 1 ml (20 drops) once daily for chronic dryness of mucous membranes or deficiency of fat-soluble vitamins.

Enhanced Dosage (Oil Infusion): For severe skin inflammations, psoriasis, eczema, and skin fissures, application of 5–7 ml of oil to the lesions 3–4 times a day is permissible. Internal use up to 1.5 ml is permissible for pronounced hormonal dysfunction, but no more than 10 consecutive days.

Maximum Dosage (Oil Infusion): External use up to 20 ml per day (in several doses), internally — up to 2 ml once. Maximum dosages are permissible short-term for sharply pronounced dryness of mucous membranes and exacerbation of chronic dermatoses.

Preventive Dosage (Oil Infusion): Externally — 2–3 ml of oil applied to the skin after a shower once daily. Internally — 0.5 ml daily, in the morning before meals. Recommended for chronic dry skin, age-related changes, climacteric syndrome, and increased hair fragility.

Pediatric Dosage (Oil Infusion): Used externally in children from 3 years of age. Permissible volume — up to 1 ml of oil per zone, 1–2 times a day. Recommended for atopic dermatitis, diaper rash, dry skin, and lip fissures. Internal use in children is not recommended.

Contraindications (Oil Infusion): Individual intolerance, acute pustular skin lesions, active dermatomycoses. Internal use is contraindicated in cholecystitis, gallstone disease, and pregnancy. Data on contraindications during lactation and in children under 3 years of age have not been registered.

Side Effects (Oil Infusion): May occur: local irritation, hyperemia, allergic reactions. With internal intake, nausea and diarrhea are possible, especially when exceeding 2 ml per day.

Adjustment for Patient Body Weight (Oil Infusion): For body weight less than 60 kg — the external volume is reduced by 20%, the internal — no more than 1 ml. For body weight over 90 kg — an increase in the external dosage up to 25 ml per day is permissible.

Preparation Method (Oil Infusion): To prepare 100 ml of oil infusion, 20 g of dry crushed moringa leaves and 100 ml of organic cold-pressed sesame or grapeseed oil are used. The plant raw material is poured with oil in a glass container, tightly closed, and kept in a water bath at a temperature of 40 °C for 6 hours. After that, it is cooled, strained through linen cloth, and poured into a dark container.

Storage Conditions and Shelf Life (Oil Infusion): Store in a dark glass container at a temperature of +10 °C to +18 °C, in a place protected from light and heat. Do not store near sources of electromagnetic radiation. Shelf life — up to 6 months. After opening, use within 45 days.


Vaginal Suppositories — Moringa oleifera

Indications (Vaginal Suppositories): Bacterial vaginosis, candidal vulvovaginitis, atrophic colpitis, cervicitis, cervical erosion, postmenopausal inflammatory changes, dysbiotic conditions of the vagina, dryness of the mucous membrane, recurrent vaginal infections.

Standard Dosage (Vaginal Suppositories): 1 suppository (weighing 2 g) once daily at night for 7–10 days. Insert deep into the vagina in a lying position. Combination with external moringa oil-based products is possible.

Enhanced Dosage (Vaginal Suppositories): 2 suppositories per day (morning and evening) for 5–7 days for pronounced candidal or bacterial inflammation, cervicitis, and pronounced itching and burning of the mucosa. Course — no more than 7 days.

Maximum Dosage (Vaginal Suppositories): Up to 3 suppositories per day is permissible under inpatient supervision for acute exacerbation of erosive-inflammatory processes, pronounced dryness, and microcracks. Duration — no more than 3 days.

Preventive Dosage (Vaginal Suppositories): 1 suppository every other day at night, course — 10 suppositories. Indicated for chronic vaginosis, postmenstrual dysbiosis, climacteric changes of the vagina, and a tendency to recurrent candidiasis. Repeat course — after 2 months.

Pediatric Dosage (Vaginal Suppositories): Use in children and adolescents under 18 years of age is not recommended due to the absence of scientific safety data. If necessary, alternative forms are selected individually.

Contraindications (Vaginal Suppositories): Hypersensitivity to components, acute purulent processes in the lesser pelvis, profuse bleeding from the genital tract of unclear etiology. There are no data on contraindications during pregnancy and lactation; use in late stages requires medical consultation.

Side Effects (Vaginal Suppositories): Local reactions: burning, itching, increased discharge. Rarely — contact dermatitis of the mucous membrane. In case of overdose (more than 2 suppositories per day), hyperemia and local swelling are possible.

Adjustment for Patient Body Weight (Vaginal Suppositories): No correction is required, since the form is administered locally and practically does not cause systemic absorption.

Preparation Method (Vaginal Suppositories): For 100 g of base, the following are used: cold-pressed moringa oil — 60 g, beeswax — 20 g, cocoa butter — 20 g. Dry moringa extract (5:1) — 5 g is introduced into the composition. Melt the oil base in a water bath at a temperature of 50 °C, introduce the extract, stir thoroughly, and pour into molds of 2 g. Cool until solidified. Store in the refrigerator.

Storage Conditions and Shelf Life (Vaginal Suppositories): Store in the refrigerator at a temperature of +2 °C to +8 °C, in the original packaging, away from sources of light and EMI. Shelf life — 6 months. After opening the blister, use within 5 days.


Rectal Suppositories — Moringa oleifera

Indications (Rectal Suppositories): Chronic colitis, proctitis, hemorrhoids, anal fissures, inflammation of the rectum, post-infectious intestinal dysbiosis, hypovitaminosis, systemic inflammation in autoimmune conditions, irritable bowel syndrome.

Standard Dosage (Rectal Suppositories): 1 suppository (weighing 2 g) rectally at night for 10 days. Insert after bowel emptying, preferably in a lying position. If necessary, the course can be repeated after a 5-day break.

Enhanced Dosage (Rectal Suppositories): 2 suppositories per day (morning and evening) for pronounced inflammation, hemorrhoidal crisis, acute forms of proctitis, and mucosal irritation. Duration — no more than 7 days.

Maximum Dosage (Rectal Suppositories): 3 suppositories per day are permitted short-term (up to 3 days) under inpatient supervision for ulcerative lesions of the rectal mucosa, bleeding anal fissures, and acute colitis.

Preventive Dosage (Rectal Suppositories): 1 suppository every other day, course — 10 suppositories. Recommended for chronic colitis, sedentary lifestyle, a tendency to constipation, post-infectious disorders of intestinal microflora, and in the off-season.

Pediatric Dosage (Rectal Suppositories): Permitted in children over 7 years of age with a body weight from 25 kg, 0.5 suppository (cut lengthwise with a knife) once daily for hypovitaminosis, dysbiosis, and irritated colon. Not recommended for children under 7 years of age.

Contraindications (Rectal Suppositories): Acute rectal bleeding, oncological diseases of the colon, allergy to components. Scientific data on contraindications during pregnancy, lactation, and in children under 7 years of age are absent.

Side Effects (Rectal Suppositories): Local irritation, itching, increased stool frequency, burning sensation. When the dosage is exceeded — increased peristalsis, flatulence, and spastic pain in the lower abdomen.

Adjustment for Patient Body Weight (Rectal Suppositories): For weight less than 60 kg — the standard dose does not change, but the course is shortened to 7 days. For weight over 90 kg — use of 2 suppositories per day for 10 days is possible.

Preparation Method (Rectal Suppositories): For 100 g of base, the following are used: cold-pressed moringa oil — 50 g, cocoa butter — 30 g, beeswax — 20 g, dry moringa extract (10:1) — 5 g. Melt the oil base in a water bath at a temperature of 50 °C, add the extract, stir, and pour into molds of 2 g. Cool until completely solidified and packaged.

Storage Conditions and Shelf Life (Rectal Suppositories): Store in the refrigerator at a temperature of +2 °C to +8 °C in a tightly closed package, away from sources of heat, light, and electromagnetic radiation. Shelf life — up to 6 months. After opening the package, use within 7 days.


Nasal Drops — Moringa oleifera

Indications (Nasal Drops): Chronic rhinitis, vasomotor rhinitis, allergic rhinitis, atrophic rhinitis, nasal congestion, post-viral hyposmia, inflammation of the nasal mucosa in chronic sinusitis, mucosal irritation after inhalation of chemicals.

Standard Dosage (Nasal Drops): 1–2 drops into each nostril 2–3 times a day. Duration of use — up to 7 days. Before use, it is recommended to cleanse the nasal passages.

Enhanced Dosage (Nasal Drops): 3 drops into each nostril 3–4 times a day is permissible for exacerbation of chronic rhinitis, severe nasal congestion, and pronounced mucosal edema. Course — no more than 5 consecutive days.

Maximum Dosage (Nasal Drops): Up to 4 drops 4 times a day is permissible short-term (no more than 3 days) for vasomotor rhinitis and allergic reactions with pronounced edema. Requires monitoring for mucosal irritation.

Preventive Dosage (Nasal Drops): 1 drop into each nostril once daily in the morning. Recommended for a tendency to chronic rhinitis, seasonal allergies, and weakened sense of smell after acute respiratory viral infections. Course — 10 days with repetition once a month.

Pediatric Dosage (Nasal Drops): Use is permissible from 6 years of age. 1 drop into each nostril 1–2 times a day for allergic rhinitis, frequent colds, and grade I adenoids. Course — 5–7 days. If necessary, repeat after a week.

Contraindications (Nasal Drops): Individual sensitivity, acute purulent sinusitis, nosebleeds, nasal mucosal injury. Data on contraindications during pregnancy and lactation have not been registered; use in children under 6 years of age is not recommended.

Side Effects (Nasal Drops): Burning, sneezing, short-term increase in nasal congestion. When the dosage is exceeded, headache and mucosal irritation are possible.

Adjustment for Patient Body Weight (Nasal Drops): No dosage adjustment is required, since the dosage form is intended for local use and does not have a systemic effect.

Preparation Method (Nasal Drops): To prepare 100 ml of drops: 50 ml of fresh moringa leaf juice, 48 ml of distilled water, 2 ml of natural glycerin. The leaves are washed, crushed to a pulp state, and squeezed. The juice is filtered through gauze, then mixed with the other components and sterilized at a temperature of 70 °C for 15 minutes. Poured into glass dropper bottles.

Storage Conditions and Shelf Life (Nasal Drops): Store in the refrigerator at a temperature of +4 °C to +8 °C, in darkened glassware, away from electromagnetic sources. Shelf life — 14 days. After opening, use within 5 days.


Ear Drops — Moringa oleifera

Indications (Ear Drops): Acute external otitis, cerumen plug, itching in the auricle, microtraumas and skin fissures of the external auditory canal, chronic dermatitis of the auditory canal, post-infectious skin changes of the ear.

Standard Dosage (Ear Drops): 2 drops into each ear canal twice daily. Course of use — 5–7 days. After instillation, lie on the side for 5 minutes for even distribution of the preparation.

Enhanced Dosage (Ear Drops): 3 drops 3 times a day for pronounced inflammation, itching, microcracks, and irritation after using ear tampons or probes. Duration — up to 5 days. Combination with warm compresses is possible.

Maximum Dosage (Ear Drops): Up to 4 drops 4 times a day for 3 days — permissible in case of intense itching, hyperemia, irritation after mechanical ear cleaning, or as part of complex therapy for external otitis. Then the dosage is reduced.

Preventive Dosage (Ear Drops): 1 drop into each ear canal once every 3 days for a tendency to dermatitis of the auditory canal, when using hearing aids, and with excessive earwax formation. Preventive course — 3 weeks.

Pediatric Dosage (Ear Drops): Use is permissible in children over 5 years of age, 1 drop once daily for itching, dry skin of the auditory canal, and irritation from headphones. Course — no more than 5 days. Do not use in the presence of perforation of the eardrum.

Contraindications (Ear Drops): Perforation of the eardrum, acute otitis media, purulent discharge from the ear, individual intolerance. There are no scientific data on contraindications during pregnancy, lactation, and in children under 5 years of age, but use is limited.

Side Effects (Ear Drops): Short-term burning, itching, increased discharge. When the dosage is exceeded, swelling of the auditory canal and hypersensitivity are possible.

Adjustment for Patient Body Weight (Ear Drops): No dosage adjustment is required, since the form acts locally and systemic absorption is insignificant.

Preparation Method (Ear Drops): To prepare 100 ml: cold-pressed moringa oil — 80 ml, calendula oil — 10 ml, fresh moringa leaf juice — 10 ml. The leaf juice is squeezed from fresh plant raw material, filtered, and mixed with oils heated to 40 °C. The mixture is stirred thoroughly and poured into dark glass dropper bottles.

Storage Conditions and Shelf Life (Ear Drops): Store in a dark, cool place at a temperature of +4 °C to +8 °C, in a tightly closed container protected from light and EMI. Shelf life — up to 3 months. After opening, use within 10 days.


Ointment — Moringa oleifera

Indications (Ointment): Psoriasis, eczema, dermatitis, skin fissures, ulcerative lesions, diaper rash, insect bites, first-degree burns, inflammation of skin folds, seborrheic dermatitis, localized skin allergic reactions.

Standard Dosage (Ointment): Apply 1–2 times a day to affected skin areas in a layer up to 1 mm thick, slightly rubbing in. Course of use — 7–10 days, if necessary can be extended to 14 days.

Enhanced Dosage (Ointment): 3 times a day for pronounced inflammatory manifestations (erythema, edema, itching), in acute phases of dermatitis, scratching, and non-infected trophic ulcers. Use for 5–7 days.

Maximum Dosage (Ointment): Up to 4 applications per day with the use of up to 5 g of ointment per 1 area, permissible no more than 3 consecutive days for intense inflammations, including localized psoriatic lesions and first-degree burns. Then return to the standard dose.

Preventive Dosage (Ointment): Once daily in the evening, course of 10 days. Used for a tendency to dry skin, the appearance of fissures, irritation from wind and solar radiation, in the off-season, and when switching to a new soap, cosmetics, or clothing.

Pediatric Dosage (Ointment): Use is permissible in children from 2 years of age. Apply in a thin layer to affected skin areas once daily. For itching, atopic dermatitis, and diaper irritation — 0.5–1 g of ointment. Do not apply to extensive areas in children under 6 years of age.

Contraindications (Ointment): Individual intolerance to components. Do not apply to open wounds, infected areas, eyes, and mucous membranes. Scientific data on contraindications during pregnancy and lactation have not been registered. Use in children under 2 years of age — with caution.

Side Effects (Ointment): Rarely: contact dermatitis, hyperemia, increased itching. Possible with prolonged use for more than 14 consecutive days or exceeding the dose.

Adjustment for Patient Body Weight (Ointment): Not required, since the form is intended for local use.

Preparation Method (Ointment): To prepare 100 g of ointment: cold-pressed moringa oil — 50 g, beeswax — 20 g, shea butter — 25 g, dry moringa extract (10:1) — 5 g. The oils are melted in a water bath at a temperature of 45 °C, the powdered extract is added, stirred thoroughly, the mixture is cooled to 30 °C, and poured into sterile pharmaceutical jars.

Storage Conditions and Shelf Life (Ointment): Store in a dark, cool place at a temperature of +5 °C to +12 °C. Do not allow overheating, freezing, and exposure to electromagnetic fields. Shelf life — 6 months. After opening — no more than 30 days.


Cream — Moringa oleifera

Indications (Cream): Dry skin, sensitive skin, age-related changes, couperose, irritation after shaving, wrinkle prevention, restoration of the skin barrier, allergic dermatitis, mild forms of eczema, post-acne.

Standard Dosage (Cream): Apply twice daily to cleansed skin in a thin layer: in the morning — for protection, in the evening — for restoration. The amount of cream — 1–2 ml per facial area or 3–5 ml per local body areas.

Enhanced Dosage (Cream): Up to 3 applications per day (morning, afternoon, evening) in the presence of peeling, irritation, and contact with irritating agents (wind, chlorinated water, cosmetics). Apply up to 7 consecutive days, then switch to the standard regimen.

Maximum Dosage (Cream): Up to 4 applications per day, 5 ml per face and up to 10 ml per body, used short-term (1–3 days) for acute manifestations of dryness, after chemical peels or photodermatoses. Not recommended on a permanent basis.

Preventive Dosage (Cream): 1 application per day in the evening, in courses of 10–14 days, once a month. Recommended for sensitive skin, under conditions of climate change, seasonal exacerbations of dermatitis, and in adulthood as anti-age care.

Pediatric Dosage (Cream): Use is permissible in children from 3 years of age. Apply once daily to dry or irritated skin (0.5–1 ml), especially for peeling, after sun exposure, and for contact dermatitis from clothing.

Contraindications (Cream): Individual intolerance. Do not apply to weeping eczema, pustular skin lesions, and acute inflammations. Data on contraindications during pregnancy and lactation have not been registered. Not recommended for children under 3 years of age.

Side Effects (Cream): Rarely: redness, burning sensation, peeling. More often when applied to damaged skin or in case of allergy to oils. In case of overdose — pore congestion, irritation.

Adjustment for Patient Body Weight (Cream): Not required, since the cream is applied externally and dosed by the application area.

Preparation Method (Cream): For 100 g of cream: chamomile hydrolate — 40 ml, cold-pressed moringa oil — 20 ml, jojoba oil — 10 ml, lecithin-based emulsifier — 7 g, beeswax — 5 g, vegetable glycerin — 10 ml, dry moringa extract (10:1) — 3 g, benzoic acid-based preservative — 0.5 g. Heat the aqueous phase (hydrolate + glycerin) to 65 °C, the oil phase (oils, wax, emulsifier) — to 70 °C. Combine the phases, add the extract, whip to a cream consistency, cool to 30 °C, and package into tubes.

Storage Conditions and Shelf Life (Cream): Store at a temperature of +5 °C to +15 °C in a tightly closed container, away from sunlight and heat sources. Shelf life — 3 months. After opening — use within 30 days.


Serum — Moringa oleifera

Indications (Serum): Increased skin sensitivity, dull complexion, enlarged pores, early wrinkles, photoaging, oily and combination skin, post-acne inflammations, dehydration, decreased skin tone, irritation after cosmetic procedures.

Standard Dosage (Serum): Apply once daily in the evening after washing to dry facial skin in a volume of 0.5–1 ml. Distribute evenly over the face, avoiding the eye area. If necessary, apply a moisturizing cream after 15 minutes.

Enhanced Dosage (Serum): Apply 2 times a day — morning and evening — 1 ml to the face and neck for pronounced skin dehydration, dullness, and the presence of inflammations. Course duration — 10–14 days, then — transition to the standard regimen.

Maximum Dosage (Serum): Up to 3 applications per day, 1.5 ml per whole face, permissible short-term (no more than 3 days) for intense skin reaction after sun, chemical peels, or stress. Recommended under medical supervision.

Preventive Dosage (Serum): Once every 2 days at night, 0.5 ml, course of 3 weeks, repeat once a season. Suitable for sensitive skin, for the prevention of irritations, in the off-season, when working in a dry room or against the background of mild dermatological manifestations.

Pediatric Dosage (Serum): Not used in children under 12 years of age. In adolescents from 12 years of age with oily and inflamed skin — spot application of serum once daily, no more than 0.25 ml, is permissible. Duration — no more than 5 consecutive days.

Contraindications (Serum): Allergy to components, acute inflammations with weeping elements, fresh burns, herpes in the active stage. There are no scientifically confirmed contraindications during pregnancy and lactation, but use requires individual assessment.

Side Effects (Serum): Rarely: mild burning, peeling, isolated elements of irritation. In case of overdose — pore congestion, hyperemia. Cease upon discontinuation of the preparation.

Adjustment for Patient Body Weight (Serum): Not required — used exclusively externally in microdoses; the dosage is adjusted only by skin type.

Preparation Method (Serum): For 100 ml: lavender hydrolate — 50 ml, water-soluble moringa extract (5:1) — 3 g, hyaluronic acid (low molecular weight) — 1 g, panthenol — 2 g, vegetable glycerin — 10 ml, sorbic acid-based preservative — 0.3 g, purified water — up to 100 ml. All components are combined at a temperature not exceeding 35 °C, the mixture is stirred to a homogeneous texture and poured into dispenser bottles.

Storage Conditions and Shelf Life (Serum): Store in the refrigerator at a temperature of +4 °C…+8 °C in an opaque glass bottle with a dispenser. Shelf life — up to 60 days. After opening, use within 21 days.


Toxicity and Biosafety of Moringa oleifera

Toxicological study data confirm the high biosafety of moringa leaves and seeds with oral administration. In preclinical animal studies, it has been determined that the acute oral toxicity (LD₅₀) of aqueous and ethanol extracts of Moringa oleifera leaves exceeds 5000 mg/kg body weight, which classifies the plant as practically non-toxic according to the Hodge and Sterner scale.

The oil extract of the seeds also demonstrated the absence of toxic action at doses up to 4000 mg/kg. With repeated administration for 14–28 days in laboratory rats, no pathomorphological changes in internal organs or disturbances of hematological and biochemical parameters were detected. Signs of mutagenicity, carcinogenicity, or embryotoxicity have not been registered to date.

Thus, Moringa oleifera in therapeutic dosages is considered pharmacologically safe for use in nutraceuticals, cosmetics, and medicinal preparations. However, high doses, especially of root extracts, may possess mild emmenagogic activity and require caution during pregnancy.

Reference: https://www.ncbi.nlm.nih.gov/p...


Pharmacodynamics — Moringa oleifera

Moringa oleifera possesses a wide spectrum of pharmacodynamic properties due to the high content of biologically active substances, including glucosinolates, isothiocyanates, flavonoids (especially kaempferol and quercetin), alkaloids, saponins, phenolic acids, as well as vitamins A, C, E, and polyunsaturated fatty acids. These compounds provide effects at both the cellular and systemic levels, with both local and systemic effects observed.

At the level of enzyme systems, moringa exhibits pronounced antioxidant activity, realized through activation of superoxide dismutase, catalase, and glutathione peroxidase, which leads to a decrease in lipid peroxidation. Inhibition of xanthine oxidase activity and a reduction in the formation of reactive oxygen species have also been established. Such properties contribute to a general cytoprotective and membrane-stabilizing action.

In the endocrine system, moringa modulates the activity of thyroid enzymes and influences the levels of leptin, adiponectin, and glucose transporters, which is confirmed by in vivo and in vitro experiments. An influence on the levels of insulin-like factors is also observed, which indirectly confirms a modulating effect on glucose and fat metabolism.

With respect to the immune system, Moringa oleifera exhibits immunomodulatory properties, including enhanced lymphocyte proliferation, stimulation of phagocytosis, and an increase in the level of serum IgG. An increase in the production of interleukin-2 (IL-2) and interferon-γ (IFN-γ) has also been established, which indicates stimulation of the T-cell response. Some components of the leaves have an inhibitory effect on the activity of the pro-inflammatory cytokines TNF-α and IL-6.

In the gastrointestinal system, moringa exhibits a mild protective effect on the mucous membrane, mediated by antioxidants and tannins. Regulation of secretory function is accompanied by a decrease in the secretion of hydrochloric acid and enhanced mucus formation, as well as potential modulation of motor activity.

In the cardiovascular system, a decrease in vascular resistance has been recorded due to the vasodilating action of flavonoids and a decrease in the sensitivity of angiotensin receptors. An antiaggregatory effect is also observed, presumably associated with an influence on the synthesis of prostacyclin and nitric oxide.

On the nervous system, moringa has a neuroprotective and adaptogenic effect. This is associated with the activity of flavonoids and phenolic compounds that modulate the levels of dopamine, serotonin, and gamma-aminobutyric acid. The plant also demonstrates antinociceptive activity under conditions of acute stress exposure.

On the skin, moringa acts locally, exhibiting anti-inflammatory, reparative, and antibacterial effects. Phytosterols, vitamins A and E, as well as fatty acids (especially oleic and behenic) contribute to the restoration of the skin barrier, a decrease in transepidermal water loss, and a reduction in oxidative stress.

The mechanisms of action of most active components of moringa are based on interaction with membrane and cytosolic receptors, antioxidant enzymes, mediator pathways (NF-κB, MAPK, PI3K/Akt), and enzymes of lipid and sugar metabolism. The chemical profile of the plant allows us to speak of a multiplicity of pharmacological targets and the polysystemic nature of its action.

References:
https://www.ncbi.nlm.nih.gov/p...
https://www.sciencedirect.com/...
https://pubmed.ncbi.nlm.nih.go...
https://www.mdpi.com/2072-6643...


Pharmacokinetics — Moringa oleifera

The pharmacokinetic behavior of the biologically active compounds of Moringa oleifera varies depending on the route of administration, the type of extracted fractions, and accompanying components. The most common routes of use are oral and transdermal, less often local and mucosal application (including vaginal and rectal administration) are used.

With oral administration of moringa powder or dry extract, the main absorption of flavonoids, phenolic acids, saponins, and glucosinolates occurs in the small intestine, with the participation of both active transport and passive diffusion. Some compounds undergo primary destruction by the intestinal microflora, forming biologically active metabolites possessing antioxidant and immunomodulatory properties. The assimilation of lipophilic components, such as phytosterols and fatty acids, depends on the accompanying intake of fats and bile acids, which promote their emulsification and micellar absorption.

Extracts obtained by alcohol methods are characterized by faster absorption of polar flavonoids; however, they are subject to the "first-pass" effect through the liver, where most phenolic and isothiocyanate compounds are conjugated with glucuronic or sulfuric acid. The resulting conjugates are distributed predominantly in the liver, kidneys, and spleen, demonstrating selective accumulation in organs with a high metabolic level.

Local application of oil forms (infusions, ointments, creams) is accompanied by the penetration of active substances through the epidermal barrier. Fat-soluble fractions penetrate best: terpenes, phytosterols, and tocopherols. They interact with the lipid layers of the stratum corneum of the skin, contributing to its plasticity and reducing transepidermal water loss. When applied to mucous membranes (vaginal or rectal suppositories), bioavailability increases due to the high vascularization of these areas, bypassing the first-pass effect through the liver. This provides a systemic effect with minimal load on the detoxification organs.

Transformations of the active substances of moringa in the liver occur with the participation of cytochrome P450 enzymes, as well as phase II enzymes — glucuronidation and sulfation. Metabolic products are excreted predominantly with bile (fat-soluble components) and urine (hydrophilic metabolites), to a lesser extent — with sweat and respiration. Some polyphenolic residues can be reabsorbed in the intestine (enteral cycle) in the presence of stable microflora.

Prolonged use is not accompanied by cumulation of most water-soluble fractions; however, accumulation of fat-soluble components in adipocytes and the skin is possible. This is especially characteristic of oil extracts used externally and taken internally.

References:
https://www.sciencedirect.com/...
https://www.ncbi.nlm.nih.gov/p...
https://pubmed.ncbi.nlm.nih.go...
https://www.mdpi.com/2227-9717...


Mechanisms of Action and Scientific Rationale — Moringa oleifera

The mechanisms of action of Moringa oleifera are mediated by a wide spectrum of biologically active compounds, including flavonoids, glucosinolates, isothiocyanates, alkaloids, saponins, and phenolic acids. One of the key directions is the inhibition of pro-inflammatory enzyme systems — in particular, cyclooxygenase-2 (COX-2) and lipoxygenase (5-LOX), which leads to a decrease in the production of prostaglandins and leukotrienes, mediators of the inflammatory cascade. This is confirmed by a decrease in the expression of mRNA for COX-2 and TNF-α in macrophage cultures treated with moringa leaf extracts. Additionally, suppression of the activity of the nuclear factor NF-κB, involved in the transcription of pro-inflammatory cytokines such as IL-1β, IL-6, and TNF-α, has been revealed.

References: https://www.ncbi.nlm.nih.gov/p...; https://www.sciencedirect.com/...

The flavonoids contained in moringa (especially quercetin and kaempferol) possess antioxidant activity, realized through direct scavenging of free radicals (•OH, O₂•−), chelation of metal ions (Fe²⁺, Cu²⁺), and induction of the expression of endogenous antioxidant enzymes: superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx). These processes are activated through the Nrf2/ARE pathway, which leads to enhanced expression of genes encoding cytoprotective proteins. This provides protection of cellular structures (including lipid membranes and mitochondria) from oxidative damage.

References: https://www.mdpi.com/2227-9717...; https://www.ncbi.nlm.nih.gov/p...

In neurohumoral regulation, the active components of moringa interact with serotonin (5-HT₁A and 5-HT₂) and dopamine receptors, as well as with GABA receptors, which is confirmed by behavioral tests in animals and electrochemical analyses in vivo. Such interactions provide a sedative and anxiolytic effect and also modulate stress reactivity. A decrease in cortisol levels and normalization of HPA-axis parameters indicate an indirect influence on the neuroendocrine system. Some isothiocyanates also inhibit acetylcholinesterase (AChE) activity, which potentially increases the level of acetylcholine in the synaptic cleft.

References: https://pubmed.ncbi.nlm.nih.go...; https://www.sciencedirect.com/...

The immunomodulatory action of Moringa oleifera is realized through an influence on macrophages and T cells. Under the action of polyphenols, the production of interleukin-2 (IL-2) and γ-interferon (IFN-γ) is enhanced, which activates cellular immunity. Individual saponins stimulate phagocytic activity and increase the level of class G immunoglobulins (IgG). Simultaneously, a decrease in the production of IL-6 and TNF-α is observed, which indicates the ability to balance the pro-inflammatory and regulatory immune response.

References: https://www.ncbi.nlm.nih.gov/p...; https://pubmed.ncbi.nlm.nih.go...

The modulation of metabolic processes is carried out through the activation of AMP-dependent protein kinase (AMPK), which participates in the regulation of energy metabolism, lipolysis, and glucose uptake. The phenolic compounds of moringa influence the expression of PPAR-γ receptors associated with fatty acid metabolism and insulin sensitivity. Additionally, the activity of α-glucosidase and α-amylase — key enzymes of carbohydrate metabolism — is inhibited, which slows down the hydrolysis of polysaccharides.

References: https://www.tandfonline.com/do...; https://www.mdpi.com/2072-6643...

Thus, the biologically active substances of Moringa oleifera realize a multicomponent and multisystem action, engaging receptor, enzyme, and signaling pathways, which allows this taxon to be classified as phyto-complexes with polyfunctional regulatory activity.


Synergy — Moringa oleifera

The pharmacological synergy of Moringa oleifera with other plant and natural substances has been confirmed in a number of in vitro, in vivo experiments and within the framework of clinically oriented studies. The most significant synergistic interactions have been established in the spheres of antioxidant, anti-inflammatory, antimicrobial, and metabolic regulation.

The combination of moringa leaf extract with curcumin (from Curcuma longa) demonstrates a potentiating antioxidant effect due to the joint activation of the transcription factor Nrf2 and enhanced expression of the enzymes superoxide dismutase, catalase, and glutathione reductase. At the same time, an additive effect is observed in the suppression of lipid peroxidation, a decrease in the level of malondialdehyde, and the restoration of redox homeostasis in the cells of the liver and brain.

Reference: https://www.ncbi.nlm.nih.gov/p...

The combination of moringa with green tea (Camellia sinensis) demonstrated potentiation of the antibacterial action due to polyphenolic synergy. The combined use of aqueous extracts enhances the inhibitory effect on gram-positive bacteria (in particular, Staphylococcus aureus) and enhances the dysfunction of bacterial membranes. The presumed mechanism is the simultaneous destruction of cell walls and inhibition of the activity of bacterial hydrolases.

Reference: https://www.sciencedirect.com/...

Studies of the interaction of moringa with cinnamon bark (Cinnamomum verum) show an additive and modulating effect with respect to glucose metabolism. This is due to the parallel influence on the enzymes α-glucosidase and α-amylase, as well as potentiation of the activation of PPAR-γ receptors. Such synergy enhances the cellular response to insulin and contributes to enhanced tissue glucose uptake, predominantly in skeletal muscle.

Reference: https://www.tandfonline.com/do...

When moringa is combined with aloe extract (Aloe vera), a modulating effect in the regeneration of skin integuments is noted, especially with transdermal administration in the form of creams and gels. Enhanced epithelialization, acceleration of fibroblast activity, and suppression of pro-inflammatory cytokines in the area of damage have been established. Synergism is achieved due to the combined action on epidermal cells, NF-κB activity, and the local level of interleukins.

Reference: https://www.sciencedirect.com/...

In combination with ginger (Zingiber officinale), moringa demonstrates a potentiating influence on anti-inflammatory cascades, including inhibition of NO and TNF-α, as well as a decrease in the expression of iNOS and COX-2 in macrophages. Such interaction enhances the anti-inflammatory action at the systemic and tissue levels, especially with the participation of immune cells. The nature of the interaction is predominantly additive, with elements of receptor modulation.

Reference: https://www.ncbi.nlm.nih.gov/p...

Thus, Moringa oleifera demonstrates confirmed pharmacological synergy with plants containing polyphenols, terpenes, and flavonoids, which enhances its systemic and local effects due to the intersection of metabolic and signaling targets. This makes moringa a promising component in the composition of multifactorial phytotherapeutic formulas.


Geography of Use and Traditional Medicine — Moringa oleifera

Moringa oleifera is traditionally used in the folk medicine of India, Sri Lanka, Pakistan, Nepal, Bangladesh, Thailand, the Philippines, Indonesia, as well as in a number of African countries (including Ethiopia, Kenya, Nigeria, Ghana, Tanzania) and on the islands of the Caribbean basin. The plant is known in traditional systems under the names "sahajan" in Hindi, "malunggay" in Filipino, "marum" in Thai, and "shajarat al-raj" in Arab healing practice. In a number of ethnomedical traditions, moringa is considered a "tree of life" or "miracle tree," due to the breadth of its application and high nutritional and medicinal value.

In the Indian Ayurvedic tradition, moringa is mentioned in texts dating back to the 1st millennium BC, where all parts of the plant were used — leaves, seeds, flowers, pods, roots, and resin. The leaves were usually used in the form of fresh juice, paste, or decoction; the seed oil was used for rubbings and rubbing into the skin. In the practices of Siddha and Unani, moringa was valued for its tonic and cleansing action. Mentions of moringa are contained in the traditional treatise "Bhavaprakasha Nighantu," where its taste and energy characteristics in the dosha system are described.

In Sri Lanka, moringa leaves are part of medicinal soups and pastes used in the folk medicine of the Sinhalese. In the folklore of Nigeria, the plant is considered sacred and is used in rites of protection and purification of the dwelling, as well as a ritual component when laying a new house. In Kenya and Tanzania, young pods are used as part of ritual food, and the seed oil was used by women in oil rubbings in preparation for wedding ceremonies.

In Thailand, moringa (มะรุม) is part of both northern (Lanna) and central folk medicine. Here the leaves and seeds are used in the form of aqueous decoctions, infusions, and wraps, especially in the context of postpartum recovery. In some northern provinces, according to ethnographic descriptions, moringa is part of traditional bath preparations (luk prakop) used in steam therapy.

In the Philippines, moringa plays an important role in folk culture. The "malunggay" leaves are used in decoctions, applied to the skin, and are part of ritual dishes offered to ancestral spirits. In folk tradition, the plant is considered to bring fertility and well-being to the home. In the Muslim communities of Southeast Asia, moringa is revered for its cleansing power and is included in the rituals of ablution and purification of the dwelling.

In the Caribbean region, the plant has been known since colonial times, when it was brought with African slaves. Here moringa was used in Jamaican folk medicine (bush medicine) in the form of tinctures, powders, and ointments. In addition, in the culture of the Maroons (freed slaves), moringa leaves were used in rites of expelling evil and as a component in smoking mixtures in the context of protective ceremonies.

In the historical-archaeobotanical context, mentions of moringa have been recorded in Egyptian medical papyri, where the use of seed oil for skin care and in religious rites is noted. The oil was used for anointings and in the composition of incense, as well as a preservative in mummification.

Thus, moringa occupies an important place in the ethnomedical and cultural traditions of various peoples, combining nutritional, medicinal, and ritual significance. Its use covers a wide geographical range from South Asia to the Caribbean region and forms a stable part of the plant cultural heritage.



Specifications
Product type Powder, Extract
Weight 100 g
Made by Asiabiopharm Co Ltd
Country of origin Thailand
Reviews